London-listed GCC healthcare provider NMC has entered sub-Saharan Africa for the first time, through hospital management contracts and a greenfield IVF clinic. The move coincides with the release of its H1 results which we look at.
Private equity investor Mid Europa has entered the Serbian private healthcare market for the first time, with the acquisition of hospital operator MediGroup. We speak to a partner at seller Blue Sea Capital.
Stripping away M&A and financial things like indebtedness, all for-profit healthcare businesses will succeed or fail based on these three parameters. And all can be measured along them, too.
Pan- European and Indian healthcare and diagnostics provider Medicover is entering the wellness market, in a move that could provide interesting synergies with its corporate healthcare offering, mainly in Poland and Romania. The company's H1 and second quarter financials show losses in the Indian and UK fertility markets, but strong growth in Eastern Europe. We […]
A quiet healthcare revolution is taking place in the Czech Republic. For the first time in almost two decades, providers and payors have reached an agreement on fees without the need for intervention by the Ministry of Health. Healthcare Europa speaks to an operator who says this is great news for private providers and a large step towards the creation of a more open market.
IVF operators at HBI 2018 told delegates that part of growing an international IVF business could be investing in a sizeable genetics lab to serve a wide network.
A disappointing birth rate saw profits plunge at Harmonicare Medical Holdings, the largest private Chinese hospital group dedicated to gynaecology, obstetrics and paediatrics, despite China scrapping its single child policy. The company's 2017 FY report shows Harmonicare’s net profit dropped by 71% to RMB27.39m (US$6.8m) and diluted earnings per share also plunged by 71% to RMB36.10 (US$5.7m). EBITDA also […]
As one of the world's largest private equity groups enters the sector, we talk to a healthcare M&A specialist who has worked on European IVF deals who thinks prices are too high.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.